Symptoms and Disease Progression in PLS
At a Glance
Primary lateral sclerosis usually causes slowly worsening stiffness that may begin in the legs and later affect the arms, speech, or swallowing. Symptoms vary between people, so regular check-ins with a neurologist and early mobility or speech support help guide safe, practical care.
Because Primary Lateral Sclerosis (PLS) is a chronic, long-term condition, understanding its patterns can help you and your care team prepare for the future. While every person’s experience is unique, the disease often follows a common “ascending” path, moving from the lower body upward over many years [1][2].
The Typical Path of Progression
For most people with PLS, the first signs appear in the legs. You might notice your gait becoming stiff or “clumsy,” or find yourself tripping more often [1]. In one large study, roughly 79% of patients in the cohort first noticed symptoms in their lower limbs [2].
Over several years, this stiffness typically spreads in an ascending progression:
- Lower Limbs: Stiffness, tightness, and a “heavy” feeling in the legs [1].
- Upper Limbs: After years of leg symptoms, you may notice similar stiffness in your hands and arms, making fine motor tasks like buttoning a shirt more difficult [3].
- Bulbar Region: This refers to the muscles in the face, mouth, and throat that control speech and swallowing. While this usually happens later, a smaller group of patients (about 9% to 19%) may experience these symptoms first [4][5].
It is important to explicitly state that upper-limb or bulbar onset is also possible, and symptoms do not have to reach every listed region. Your neurologist will interpret your pattern individually.
Stiffness vs. Weakness: Knowing the Difference
In PLS, the primary issue is spasticity—a persistent tightness or stiffness caused by the brain sending too many “contract” signals to the muscles [6]. While you may feel weak because it is harder to move a stiff limb, upper-motor-neuron dysfunction itself can cause genuine weakness and loss of function.
It is helpful to look for what is absent or limited in PLS:
- Mild Atrophy: Unlike ALS, PLS typically does not cause significant, progressive atrophy (visible muscle wasting or shrinking), though disuse atrophy can occur [7].
- Occasional Fasciculations: You generally will not see widespread fasciculations (visible “flickering” or twitching under the skin), which are common signs of lower motor neuron involvement, but occasional twitching does occur [8].
How EMG May Help
An Electromyography (EMG) and Nerve Conduction Study assesses lower-motor-neuron and peripheral-nerve involvement. An EMG in PLS may be normal or may show minor chronic neurogenic abnormalities, but the dramatic, widespread nerve-failure patterns seen in ALS are typically not present [9][10]. No single EMG confirms PLS or reliably excludes early ALS, so interpretation and serial clinical examination matter.
Bulbar Symptoms: Speech and Swallowing
As PLS progresses toward the bulbar region, it can affect how you communicate and eat. These changes happen slowly, often over several years.
- Dysarthria: This is a change in speech quality. Your voice may sound strained, “slurred,” or slower than usual [11][12].
- Dysphagia: This is the medical term for swallowing difficulties. You might find yourself coughing more often while drinking liquids or needing more time to chew solid foods [4][13].
Pseudobulbar Affect (PBA)
One of the misunderstood symptoms of PLS is the Pseudobulbar Affect (PBA). This is a neurologic syndrome where you may suddenly burst into laughter or tears that do not match how you actually feel [14].
PBA is a neurologic syndrome distinct from mood, but depression, anxiety, grief, and PBA can coexist, and the same patient may have both [14]. It is quite common in PLS, with some studies showing it affects between 30% and 51% of patients [4][15]. Your care team should encourage assessment of mood as well as involuntary laughing or crying.
Long-Term Expectations
While PLS does not typically shorten life expectancy to the degree ALS does, it is a disabling condition that requires adaptation over time [11]. Most patients will eventually require tools to help them stay mobile and safe.
In a study of patients who had lived with PLS for a median of nine years:
- 56% used a cane or walker to assist with balance and stiffness [4].
- 20% transitioned to using a wheelchair for longer distances or daily mobility [4].
These percentages are cohort-specific and should not be presented as a strict template that every patient will follow. By working with a multidisciplinary care team early on, you can transition to these aids proactively, which helps prevent falls and preserves your energy for the activities that matter most to you.
Common questions in this guide
How does primary lateral sclerosis usually progress?
Is PLS mainly stiffness or weakness?
What can an EMG show in PLS?
What speech and swallowing changes can happen with PLS?
What is pseudobulbar affect in PLS?
When might mobility aids be useful for someone with PLS?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Primary lateral sclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my current symptoms, has the disease progressed to my upper limbs or bulbar region yet?
- 2.Are there any signs of muscle atrophy or lower motor neuron involvement that would change my diagnosis?
- 3.Can we schedule a baseline evaluation with a speech-language pathologist to monitor my swallowing and speech?
- 4.What treatments are available if my pseudobulbar affect (PBA) starts to interfere with my social life?
- 5.How often should we re-evaluate my need for mobility aids like a cane or a walker?
References
References (15)
- 1
Progression and life expectancy in primary lateral sclerosis.
Lester DG, Thompson AG, Talbot K, Turner MR
Journal of neurology, neurosurgery, and psychiatry 2025; (96(10)):1008-1011 doi:10.1136/jnnp-2025-336037.
PMID: 40379483 - 2
Genetic characterization of primary lateral sclerosis.
de Boer EMJ, de Vries BS, Pennings M, et al.
Journal of neurology 2023; (270(8)):3970-3980 doi:10.1007/s00415-023-11746-7.
PMID: 37133535 - 3
Primary lateral sclerosis: diagnosis and management.
Turner MR, Talbot K
Practical neurology 2020; (20(4)):262-269 doi:10.1136/practneurol-2019-002300.
PMID: 32217663 - 4
Natural History of "Pure" Primary Lateral Sclerosis.
Hassan A, Mittal SO, Hu WT, et al.
Neurology 2021; (96(17)):e2231-e2238 doi:10.1212/WNL.0000000000011771.
PMID: 33637635 - 5
The Epidemiology of Primary Lateral Sclerosis: Results from a Population-Based Cohort.
Vasta R, Matteoni E, Pellegrino G, et al.
Annals of neurology 2026; (99(3)):606-613 doi:10.1002/ana.78105.
PMID: 41316718 - 6
The Upper Motor Neuron-Improved Knowledge from ALS and Related Clinical Disorders.
Menon P, Vucic S
Brain sciences 2021; (11(8)) doi:10.3390/brainsci11080958.
PMID: 34439577 - 7
Primary Lateral Sclerosis.
Statland JM, Barohn RJ, Dimachkie MM, et al.
Neurologic clinics 2015; (33(4)):749-60.
PMID: 26515619 - 8
Atypical Initial Presentation of Painful Muscle Cramps in a Patient with Amyotrophic Lateral Sclerosis: A Case Report and Brief Review of the Literature.
Kuzel AR, Lodhi MU, Syed IA, Rahim M
Cureus 2017; (9(11)):e1837 doi:10.7759/cureus.1837.
PMID: 29340258 - 9
Primary lateral sclerosis: application and validation of the 2020 consensus diagnostic criteria in an expert opinion-based PLS cohort.
Witzel S, Micca V, Müller HP, et al.
Journal of neurology, neurosurgery, and psychiatry 2024; (95(8)):737-747 doi:10.1136/jnnp-2023-333023.
PMID: 38388486 - 10
Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional Population.
Fournier CN, Murphy A, Loci L, et al.
Journal of clinical neuromuscular disease 2016; (17(3)):99-105 doi:10.1097/CND.0000000000000102.
PMID: 26905909 - 11
Toward therapeutic trials in primary lateral sclerosis.
Scirocco E, Allen MD, Giacomelli E, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2025; (26(7-8)):623-630 doi:10.1080/21678421.2025.2527123.
PMID: 40618376 - 12
Differentiating upper- and lower motor neuron diseases using automated acoustic analysis.
Truong J, Simmatis L, Pommée T, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2025; (26(7-8)):691-701 doi:10.1080/21678421.2025.2506444.
PMID: 40450589 - 13
Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature.
Ramanathan RS, Rana S
Neurodegenerative disease management 2018; (8(1)):17-23 doi:10.2217/nmt-2017-0051.
PMID: 29316850 - 14
Pseudobulbar affect: clinical associations, social impact and quality of life implications - Lessons from PLS.
Finegan E, Kleinerova J, Hardiman O, et al.
Journal of neurology 2025; (272(4)):266 doi:10.1007/s00415-025-12971-y.
PMID: 40072589 - 15
Primary lateral sclerosis in Brazil: phenotypic heterogeneity, non-motor features, and prognostic markers in a 17-year multicentre cohort.
Marques Couto C, Vidal Watkins C, Silva Carvalho R, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2026; 1-10 doi:10.1080/21678421.2026.2652325.
PMID: 41974023
This page is for informational purposes only and does not constitute medical advice. Your neurologist and care team should interpret your PLS symptoms, EMG results, and progression individually.